Company Growth Strategy

At Evaluate, our mission is simple: to help patients gain access to life-saving therapies. Evaluate is a Norstella company, a collection of prominent pharmaceutical solutions providers that have joined forces to offer a full range of consultancy services and solutions. Evaluate provides life sciences clients with the right tools and expertise to navigate complexities at each step of the drug development life cycle, from pipeline to patient. Our offerings include cutting-edge data solutions, consensus forecasts and expert advisory services alongside advanced technologies such as machine learning and predictive analytics.

The Company Growth Strategy data product provides a comprehensive dataset that can be leveraged to understand and strategize the growth trajectory of a company. By leveraging these tables, users can gain a holistic understanding of a company’s growth strategy, its competitive landscape, financial viability, market demand, and significant developments impacting its growth.

The following sets of data have been included in this listing:

Drugs - Names and Identifiers: This table provides information about various drugs, their names, and unique identifiers. It can be used to understand the range of drugs a company has in its portfolio.

Drugs - Classifications: This table categorizes drugs based on their therapeutic class, mechanism of action, etc. It can help in understanding the areas of focus for a company.

Drugs - Patents & IP: This table provides information about the patents and intellectual property associated with each drug. It can be used to assess the competitive advantage of a company.

Deals - M&A: This table contains data about mergers and acquisitions involving the company. It can provide insights into the company’s growth strategy and market expansion.

Companies - Names and Identifiers: This table lists companies along with their unique identifiers. It can be used for benchmarking purposes.

Companies - Classifications: This table categorizes companies based on their industry, size, etc. It can help in understanding the competitive landscape.

Deals - Licensing, product sales, platforms: This table provides information about various deals made by the company for licensing, product sales, etc. It can provide insights into the company’s revenue streams.

Drugs - NPV (product): This table provides the Net Present Value (NPV) of each drug. It can be used to assess the financial viability of a drug.

Drugs - Predicted approvals: This table lists drugs that are predicted to get approval. It can help in forecasting the company’s growth.

Drugs - Peak sales: This table provides information about the peak sales achieved by each drug. It can be used to understand the commercial success of a drug.

Clinical trials - Dates: This table lists the dates of various clinical trials conducted by the company. It can provide insights into the company’s research and development activities.

Drugs - NPV (indication): This table provides the Net Present Value (NPV) of each drug for specific indications. It can be used to assess the potential profitability of a drug for specific indications.

Deals - VF - Investor profiles: This table provides profiles of investors involved in various deals with the company. It can provide insights into the company’s financial backing.

Once you subscribe to this listing, you will have access to all the data tables required.

Workflow:

• Consumer clicks Request button on Evaluate listing<br/>• Evaluate will reach out to the consumer and finalize terms.<br/>• Evaluate shares the data product with the consumer via Snowflake shares.

Additional Information<br/>This data product is updated regularly to ensure that you have the most recent and accurate information. If you have any questions or need further information, please don’t hesitate to contact us.

搜集汇总

背景与挑战

背景概述

该数据集提供医药公司增长战略的全面数据，包括药物信息、专利、交易记录及财务指标等，帮助用户分析公司发展轨迹和竞争格局。数据通过Snowflake共享，定期更新以确保准确性。